Global Continuous Glucose Monitoring (CGM) Market should reach nearly $20.7 billion in 2022

ResearchMoz presents professional and in-depth study of “Continuous Glucose Monitoring (CGM): Technologies and Global Markets”.

The global market for continuous glucose monitoring devices and diabetes-related products totaled nearly $12.1 billion in 2016. The market should reach nearly $12.8 billion in 2017 and $20.7 billion in 2022, registering a compound annual growth (CAGR) of 10.1% from 2017-2022.

Get PDF for more Professional and Technical insights @

Report Includes

52 data tables and 20 additional tables
An overview of the global market for continuous glucose monitoring (CGM)
Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
Examination of the critical issues within the CGM market, including technological developments, geographic trends, market dynamics, and adoption trends
Market breakdowns by application area: hospitals, diagnostics/clinics, home
Information broken down by age: children, teens, young, middle, elderly; by race: non-Hispanic whites, Hispanics, Asian-Americans, Europeans, Asians, others; and by geography: the U.S., Europe, Asia, and the rest of the world
Information on leading companies, including Abbott Labs, Apple Inc., Johnson & Johnson, Medella Health, Medtronic, Roche, Sanofi and Unilife Corp.

Report Scope

The scope of this study encompasses the current and forecast markets for glucose monitoring, as well as pumps, SMBG meters and test strips. The covered segments are CGM transmitters, receivers and sensors, patch and durable insulin pumps, and self–monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all usage of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM device. Calibration may be required once or twice a day, or even less often, as the devices improve in the near future. Inclusion of SMBG meters and test strips will help the reader to comprehend the relative sizes of the two major segments: CGM and SMBG. As discussed elsewhere in this report, developing countries will continue to use primarily SMBG, as these devices are not only much cheaper than CGM, but, for many diabetics, do just fine for monitoring blood glucose. The report also includes discussions of the reimbursement and regulatory environments, current and developing technologies, diabetes incidence, market projections and market shares, and the latest trends and clinical trials.

View Complete TOC with tables & Figures @

Table Of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background
History and Current State of Blood Glucose Monitoring Technology
SMBG Devices
Noninvasive Blood Glucose Monitoring
Electrochemical Blood Glucose Test Strips
Technical Challenges in Accurately Measuring Interstitial Glucose Levels
Use of Continuous Glucose Monitoring in Children with Type 1 Diabetes

Browse Report @

Proving the Benefits of CGM Use by All Diabetics: T1D, T2D and Gestational Diabetes Patients
Working to Improve CGM Technology
Smart sensors improve accuracy of blood glucose readings
Changing the Optimal Dosing Rules for Nonadjunctive CGM
Reducing the Number of Calibrations Needed

For More Information Kindly Contact:

Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States – 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Follow us on LinkedIn @
Follow me on :